BG Medicine Receives CE Mark
Posted on December 11, 2012 at 11:59 AM EST
BG Medicine Inc. (Nasdaq: BGMD) received the CE Mark allowing it to sell its CardioSCORE cardiovascular blood tests in the European Union. The stock price more than doubled by leaping $1.91 to $3.24.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here